Mark Eisner - 08 Mar 2023 Form 4 Insider Report for FIBROGEN INC (FGEN)

Role
Chief Medical Officer
Signature
/s/ Cecelia Monoarfa-Taime, Attorney-in-fact
Issuer symbol
FGEN
Transactions as of
08 Mar 2023
Net transactions value
-$360,572
Form type
4
Filing time
10 Mar 2023, 20:55:04 UTC
Previous filing
06 Mar 2023
Next filing
06 Apr 2023
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction FGEN Common Stock Sale $155,771 -7,363 -4.3% $21.16* 165,133 08 Mar 2023 Direct F1
transaction FGEN Common Stock Award $0 +7,732 +4.7% $0.000000 172,865 08 Mar 2023 Direct F2
transaction FGEN Common Stock Award $0 +12,451 +7.2% $0.000000 185,316 08 Mar 2023 Direct F3
transaction FGEN Common Stock Sale $78,467 -3,885 -2.1% $20.20* 181,431 10 Mar 2023 Direct F4
transaction FGEN Common Stock Sale $126,334 -6,255 -3.4% $20.20* 175,176 10 Mar 2023 Direct F5
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Represents the number of shares sold by the reporting person to cover the tax obligation realized upon the vesting of restricted stock units previously reported in Table I.
F2 Represents the number of shares released for PSU Milestone Grant vested on March 8, 2023.
F3 Represents the number of shares released for PSU TSR Grant vested on March 8, 2023.
F4 Represents the number of shares sold by the reporting person to cover the tax obligation realized upon the vesting of PSU Milestone previously reported in Table I.
F5 Represents the number of shares sold by the reporting person to cover the tax obligation realized upon the vesting of PSU TSR previously reported in Table I.